MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychogenic movement disorders(PMD): Clinical features"

  • 2025 International Congress

    Exploring the Characteristic Features of Speech and Facial Expressions in Patients with Huntington’s Disease Based on Machine Learning

    L. Lu, J. Yin, N. Yan, Y. Huang (Sydney, Australia)

    Objective: This study analyzes the speech and facial  characteristics of Huntington's disease (HD) and explores their relationship with clinical manifestations to develop machine learning models…
  • 2025 International Congress

    Japanese family of dystonia related to GNAO1 pathogenic variant and systematic literature review

    N. Kanzato, K. Nakachi, S. Teruya, T. Yamashiro, Y. Yamada, T. Oguro, H. Yoshino, N. Hattori (Haebaru-cho, Okinawa, Japan)

    Objective: To present a young adolescent female with functional dystonia phenotype progressed to status dystonia/anarthria and mental confusion, even more molecular genetic of family members…
  • 2025 International Congress

    Trends in the incidence of Functional Movement Disorders (FMD):The impact of the pandemic and other historical events

    G. Lopez, D. Marín Medina, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To analyze the incidence of Functional Movement Disorders(FMD) consultations before, during and after the COVID-19 pandemic, and the impact of published diagnostic criteria for…
  • 2025 International Congress

    Which Biomarker-Based Diagnostic Algorithm for Functional Motor Disorders Diagnosis?

    M. Gandolfi, A. Sandri, IA. Di Vico, M. Fiorio, G. Pedrotti, A. Paolicelli, P. Barone, MT. Pellecchia, R. Erro, S. Cuoco, I. Carotenuto, M. Russo, C. Vinciguerra, A. Botto, M. Amboni, G. Mansueto, FB. Pizzini, A. Tamanti, M. Barillari, MF. Lauriola, MC. Tozzi, F. Rusciano, C. Geroin, M. Fasoli, A. Marotta, E. Pizzolla, F. Salaorni, I. Lozzi, GM. Squintani, S. Mariotto, S. Tamburin, F. Paio, G. de Biasi, G. Piscosquito, L. Zenere, A. Gardoni, S. Bastia, E. Canu, E. Sibilla, M. Filippi, E. Sarasso, F. Agosta, M. Tinazzi (Verona, Italy)

    Objective: To develop a biomarker-based diagnostic algorithm for Functional Motor Disorders (FMD) diagnosis by modeling behavioral, neurophysiological, and MRI biomarkers. Background: FMD is prevalent yet…
  • 2025 International Congress

    Hair Glucocorticoids and Functional Movement Disorders Insights from a Cross Sectional Study

    VI. Lopez-Diaz, CA. Diaz-Garza, D. León Rojas, F. Luna-Rangel, M. González-González, J. Rodriguez-de-Ita, F. Castorena Torres, D. Martínez-Ramírez (Monterrey, Mexico)

    Objective: To compare hair glucocorticoid levels between patients with Functional Movement Disorders (FMD) and healthy controls. Background: FMD are complex neurological conditions that lack specific…
  • 2025 International Congress

    Changes in Functional Movement Disorders (FMD) Phenotype: A Retrospective Study

    D. Marín-Medina, G. Lopez, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To describe changes in phenotypes of Functional Movement Disorders (FMD) over time and identify associated clinical and demographic variables. Background: Like other functional neurological…
  • 2025 International Congress

    Improved Outcomes for Patients with Autonomic Movement Disorders (AMD) Originally Evaluated for Psychogenic Non-Epileptiform Spells (PNES)

    A. Khoo, J. Brik, M. Paul, A. Hohler (Boston, USA)

    Objective: To evaluate whether treating underlying dysautonomia in patients with abnormal movements initially diagnosed with psychogenic non-epileptiform spells (PNES) leads to a reduction in motor…
  • 2025 International Congress

    Sensitivity to Reward and Decision-Making in Functional Motor Disorder: a Case-Control Study

    V. Nistico', B. Gonzalez, J. da Cuna, E. Andrenelli, M. Fiorio, M. Tinazzi, F. Morgante, A. Fotopoulou, MJ. Edwards, B. Demartini, L. Ricciardi (Milan, Italy)

    Objective: To investigate decision-making abilities of patients with Functional Motor Disorders (FMD) using the Iowa Gambling Task (IGT). Background: FMD is a heterogeneous neuropsychiatric condition…
  • 2025 International Congress

    Personality Profiles in Patients with Functional Motor Disorders

    V. Nistico', S. Cuoco, R. Bisogno, R. Tedesco, C. Civilotti, O. Gambini, P. Barone, B. Demartini, R. Erro (Salerno, Italy)

    Objective: This study explores personality profiles in patients with Functional Motor Disorder (FMD) compared to healthy controls (HC) using the Minnesota Multiphasic Personality Inventory-2 (MMPI-2).…
  • 2025 International Congress

    Cognitive Biases in Movement Disorders: Implications for Clinical Decision-Making and Patient Perception of Symptoms

    N. Choudhury, D. Buonadonna, B. Carr (Gainesvile, USA)

    Objective: To explore how cognitive biases affect decision-making in patients with movement disorders, including misjudgments in symptom perception, risk-taking in treatment decisions and adherence to…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley